Novartis AG (ADR) (NVS) Beats Analyst Estimates; Is Expected To Perform Well Backed By Recent Deals

In an interview with Bloomberg, Odile Rundquist, who is an analyst at Helvea, discusses on the second Qtr. results of the world’s largest drug maker by revenue, Novartis AG (ADR) (NYSE:NVS).

“I would say first that they do not really miss estimates. I mean they were a touch below by 1% on the topline and 1% on the bottom line. So I mean it is really a very small miss,” said Rundquist.

She added that we needed to focus now on the three key divisions of the company which will be part of the continuing business of Novartis AG (ADR) (NYSE:NVS) i.e. Pharmaceutical, Alcon and Sandoz.

Novartis AG (ADR) (NYSE:NVS)

On the deal between Novartis AG (ADR) (NYSE:NVS) and Google Inc. (NASDAQ:GOOGL), Rundquist said that the deal is interesting for both the companies and the deal represents a new way to thinking in healthcare, by combining bio-technology healthcare with technology.

The technology being a non-invasive way of measuring glucose, could give real-time monitoring and treatment in case of Diabetes, said Rundquist.

On 32% of sales for the company being from so-called ‘growth products,’ Rundquist feels that it is a good figure considering many new launches since 2009 which form part of this category. She added that investors need to look at the data on Phase III of LCZ 696 in the coming months, which is a new drug for chronic heart failure and can become a $5 billion drug for the company.

In another interview, Bloomberg’s Sam Fazeli, speaking on the recent results of Novartis AG (ADR) (NYSE:NVS), said that structural changes from various deals like the one with GlaxoSmithKline plc (ADR) (NYSE:GSK) & Eli Lilly and Co (NYSE:LLY), won’t be reflecting in the company’s group financials this year, as these deals will be closing by early next year.

Fazeli added that the deal with Google Inc. (NASDAQ:GOOGL) will help in bringing more innovation into Google’s latest technology in terms of the type of lenses and that they need to convince diabetes patients also that this technology is as high-quality and sensitive as other available technologies.

“What will you see with this company is that as it products, and most pharma companies, as their products switch to more specialty care products; to more oncology type products, where the prices are healthier and the costs of selling them are lower, certainly less than if you were selling to every corner shop GP, if you like, the reality is that that automatically brings down the selling and administrative costs,” Fazeli said on lowering of administrative costs.

Disclosure: none

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Shopaholics Rejoice: The 12 Biggest Malls in the World

Fright Night: 10 Horror Movies Based on True Stories

Mach Mania: The 10 Fastest Jets in the World

Military Heavyweights: The 10 Countries with the Most Tanks

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

The Top 10 Richest Actors in the World

The 10 Best Airline Stocks to Invest In Before They Fly Too High

Burger Kings: The 10 Most Expensive Burgers in the World

The 10 Most Ethnically Diverse Countries in the World

The 10 Most Exclusive Credit Cards in the World

The 10 Most Expensive Cruise Ships in the World

The 10 Fastest Supercomputers in the World

The 10 Best Countries for Doing Business 2015

6 Most Expensive Fruits In The World

10 Worst Airlines in the World

The 10 Biggest Tax Havens in the World to Stash Your Money

The 15 Most Murderous Countries in the World

10 Largest Colleges in the World: Bigger Isn’t Always Better

Comedians in Cars Getting Coffee: The 6 Comedians Seinfeld Needs to Interview

Easy Money: The 10 Most Successful Investors in the World Today

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!